Drug Patent Expirations in December 2007
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in December 2007
*Drugs may be
covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
| DOVONEX | Leo Pharm | calcipotriene | 4,866,048 | DEC 29,2007 |
| FASLODEX | Astrazeneca | fulvestrant | 4,659,516 | DEC 11,2007 |
| KYTRIL | Roche | granisetron hydrochloride | 4,886,808 | DEC 20,2007 |
| KYTRIL | Roche | granisetron hydrochloride | 4,886,808 | DEC 29,2007 |
| MERIDIA | Abbott | sibutramine hydrochloride | 4,746,680 | DEC 11,2007 |
| REQUIP | Glaxosmithkline | ropinirole hydrochloride | 4,452,808 | DEC 07,2007 |
| TACLONEX | Leo Pharm Prods | betamethasone dipropionate; calcipotriene hydrate | 4,866,048 | DEC 29,2007 |
| ZINECARD | Pharmacia And Upjohn | dexrazoxane hydrochloride | 4,963,551 | DEC 21,2007 |
| ZYRTEC | Pfizer | cetirizine hydrochloride | 4,525,358 | DEC 25,2007 |
| ZYRTEC-D 12 HOUR | Pfizer | cetirizine hydrochloride; pseudoephedrine hydrochloride | 4,525,358 | DEC 25,2007 |
Courtesy of DrugPatentWatch.com
Extend the life of drugs with extended delivery formulations. Coreg CR developed by GSK/Flamel Technologies is an example.